BEONE MEDICINES ( FORMERLY KNOWN AS BEIGENE USA, INC.)

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2022–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	5	1
2024	—	4	1
2023	—	4	1
2022	—	4	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
WILLIAMS AND JENSEN, PLLC	—	20

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	19
SENATE	19
Centers For Medicare and Medicaid Services (CMS)	5

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Trade (domestic/foreign)	Trade (domestic/foreign)	20
Health Issues	Health Issues	20
Medicare/Medicaid	Medicare/Medicaid	20
Manufacturing	Manufacturing	20
Pharmacy	Pharmacy	6

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 830118th Congress

HELP Copays Act

2026 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.

Client expense: — · Firm income: $80,000

Matched citations: H.R.830

S. 864118th Congress

TASK Act

2026 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.

Client expense: — · Firm income: $80,000

Matched citations: S. 864

H.R. 830118th Congress

HELP Copays Act

2026 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.

Client expense: — · Firm income: $80,000

Matched citations: H.R.830

S. 864118th Congress

TASK Act

2026 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.

Client expense: — · Firm income: $80,000

Matched citations: S. 864

Show 21 more cited filings

H.R. 830118th Congress

HELP Copays Act

2026 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.

Client expense: — · Firm income: $80,000

Matched citations: H.R.830

S. 864118th Congress

TASK Act

2026 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.

Client expense: — · Firm income: $80,000

Matched citations: S. 864

H.R. 830118th Congress

HELP Copays Act

2025 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.

Client expense: — · Firm income: $80,000

Matched citations: H.R.830

S. 864118th Congress

TASK Act

2025 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.

Client expense: — · Firm income: $80,000

Matched citations: S. 864

H.R. 830118th Congress

HELP Copays Act

2025 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.

Client expense: — · Firm income: $80,000

Matched citations: H.R.830

S. 864118th Congress

TASK Act

2025 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.

Client expense: — · Firm income: $80,000

Matched citations: S. 864

H.R. 830118th Congress

HELP Copays Act

2025 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.

Client expense: — · Firm income: $80,000

Matched citations: H.R.830

S. 864118th Congress

TASK Act

2025 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.

Client expense: — · Firm income: $80,000

Matched citations: S. 864

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing and reimbursement for prescription drugs related to H.R.5376, "Inflation Reduction Act of 2022" (PL 117-169), Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.

Client expense: — · Firm income: $60,000

Matched citations: H.R.5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing and reimbursement for prescription drugs related to H.R.5376, "Inflation Reduction Act of 2022" (PL 117-169), Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.

Client expense: — · Firm income: $60,000

Matched citations: H.R.5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing and reimbursement for prescription drugs related to H.R.5376, "Inflation Reduction Act of 2022" (PL 117-169), Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.

Client expense: — · Firm income: $60,000

Matched citations: H.R.5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing and reimbursement for prescription drugs related to H.R.5376, "Inflation Reduction Act of 2022" (PL 117-169), Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.

Client expense: — · Firm income: $60,000

Matched citations: H.R.5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing and reimbursement for prescription drugs related to H.R.5376, "Inflation Reduction Act of 2022" (PL 117-169), Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.

Client expense: — · Firm income: $60,000

Matched citations: H.R.5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing and reimbursement for prescription drugs related to H.R.5376, "Inflation Reduction Act of 2022" (PL 117-169), Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.

Client expense: — · Firm income: $60,000

Matched citations: H.R.5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing and reimbursement for prescription drugs related to H.R.5376, "Inflation Reduction Act of 2022" (PL 117-169), Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.

Client expense: — · Firm income: $60,000

Matched citations: H.R.5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing and reimbursement for prescription drugs related to H.R.5376, "Inflation Reduction Act of 2022" (PL 117-169), Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.

Client expense: — · Firm income: $60,000

Matched citations: H.R.5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing and reimbursement for prescription drugs related to H.R. 5376 - Build Back Better Act, Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.

Client expense: — · Firm income: $10,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing and reimbursement for prescription drugs related to H.R. 5376 - Build Back Better Act, Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.

Client expense: — · Firm income: $10,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing and reimbursement for prescription drugs related to H.R. 5376 - Build Back Better Act, Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.

Client expense: — · Firm income: $10,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing and reimbursement for prescription drugs related to H.R. 5376 - Build Back Better Act, Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.

Client expense: — · Firm income: $10,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing and reimbursement for prescription drugs related to H.R. 5376 - Build Back Better Act, Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.

Client expense: — · Firm income: —

Matched citations: H.R. 5376

Source: Senate LDA

BEONE MEDICINES ( FORMERLY KNOWN AS BEIGENE USA, INC.) — Lobbying Disclosure | Poliscope